Testicular germ cell tumor (GCT) is the most common solid tumor in adolescent and young
adult men. Progress in the management of GCT has been made in the last 50 years, with a …

Background Radiation therapy and systemic chemotherapy are recommended treatment
options in marker-negative clinical stage (CS) IIA/B seminoma. Despite high cure rates of 82 …

Introduction Chemotherapy and radiation therapy are considered standard treatments for
stage II seminoma patients; however, these therapies are associated with long-term …

Testicle Cancer - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe
PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech …

To evaluate the oncological outcomes and safety of primary retroperitoneal lymph node
dissection (RPLND) in patients with clinical stage (CS) II seminomatous testicular germ cell …

Testicular Cancer - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Over the past half century, advancements in treatment have led to cures in an overwhelming
majority of patients with testicular germ cell tumors. Astute clinical decision-making, informed …

Simple Summary Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) is
an integral component of testicular cancer treatment, as approximately one-third of patients …

Introduction Retroperitoneal lymphadenectomy (RPLND) is well established as a primary
treatment, especially for high-risk stage I and stage IIA/B nonseminomatous tumors, but its …

Retroperitoneal lymph node dissection (RPLND) for testicular seminoma with enlarged
retroperitoneal lymph nodes has received increased consideration and exposed a new …